MetLife Investment Management’s Stride LRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.12M Buy
24,636
+1,861
+8% +$171K 0.01% 1117
2026
Q1
$2.01M Sell
22,775
-630
-3% -$51.1K 0.01% 1059
2025
Q4
$1.52M Sell
23,405
-1,643
-7% -$149K 0.01% 1215
2025
Q3
$3.73M Sell
25,048
-414
-2% -$60.7K 0.02% 766
2025
Q2
$3.7M Buy
25,462
+744
+3% +$108K 0.02% 703
2025
Q1
$3.13M Sell
24,718
-990
-4% -$125K 0.02% 839
2024
Q4
$2.67M Buy
25,708
+1,133
+5% +$108K 0.01% 899
2024
Q3
$2.1M Hold
24,575
0.01% 990
2024
Q2
$1.73M Buy
24,575
+3,132
+15% +$209K 0.01% 1051
2024
Q1
$1.35M Sell
21,443
-670
-3% -$40.4K 0.01% 1131
2023
Q4
$1.31M Hold
22,113
0.01% 1157
2023
Q3
$996K Hold
22,113
0.01% 1234
2023
Q2
$823K Hold
22,113
0.01% 1375
2023
Q1
$868K Buy
22,113
+1,198
+6% +$47K 0.01% 1294
2022
Q4
$654K Sell
20,915
-654
-3% -$24K 0.01% 1474
2022
Q3
$907K Hold
21,569
0.01% 1243
2022
Q2
$880K Sell
21,569
-1,784
-8% -$66.1K 0.01% 1277
2022
Q1
$848K Buy
23,353
+8,035
+52% +$267K 0.01% 1439
2021
Q4
$511K Hold
15,318
﹤0.01% 1498
2021
Q3
$551K Hold
15,318
﹤0.01% 1469
2021
Q2
$492K Hold
15,318
﹤0.01% 1582
2021
Q1
$461K Sell
15,318
-2,019
-12% -$52.4K ﹤0.01% 1572
2020
Q4
$368K Hold
17,337
﹤0.01% 1634
2020
Q3
$457K Hold
17,337
0.01% 1413
2020
Q2
$472K Hold
17,337
0.01% 1411
2020
Q1
$327K Hold
17,337
﹤0.01% 1446
2019
Q4
$353K Hold
17,337
﹤0.01% 1647
2019
Q3
$458K Hold
17,337
0.01% 1465
2019
Q2
$527K Sell
17,337
-34,674
-67% -$1.12M 0.01% 1447
2019
Q1
$1.78M Buy
52,011
+34,674
+200% +$1.06M 0.01% 1329
2018
Q4
$430K Hold
17,337
0.01% 1457
2018
Q3
$307K Hold
17,337
﹤0.01% 1847
2018
Q2
$284K Hold
17,337
﹤0.01% 1740
2018
Q1
$246K Hold
17,337
﹤0.01% 1780
2017
Q4
$276K Buy
+17,337
New +$288K ﹤0.01% 1756

Other funds holding LRN

MetLife Investment Management's LRN Position: Q2 2026 in Review

MetLife Investment Management increased its Stride (LRN) stake by 8.2% in Q2 2026, buying an estimated $171K and bringing the position to 24,636 shares worth $2.12M. The position accounts for 0.01% of the portfolio, ranked #1117.

MetLife Investment Management first reported a position in LRN in Q4 2017 and has held it in 35 quarters since. The position peaked at $3.73M in Q3 2025. 413 funds tracked by Wall St. Rank hold LRN as of Q2 2026.

  • MetLife Investment Management held 24,636 shares of Stride worth $2.12M as of Q2 2026.
  • MetLife Investment Management bought 1,861 Stride shares in Q2 2026, an estimated $171K.
  • Stride made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1117 holding.
  • MetLife Investment Management first reported a position in Stride in Q4 2017 and has held it in 35 quarters since.
  • MetLife Investment Management's Stride position peaked at $3.73M in Q3 2025.
  • 413 funds tracked by Wall St. Rank held Stride as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.